466 related articles for article (PubMed ID: 18175781)
1. Nephropathy in males and females with Fabry disease: cross-sectional description of patients before treatment with enzyme replacement therapy.
Ortiz A; Oliveira JP; Waldek S; Warnock DG; Cianciaruso B; Wanner C;
Nephrol Dial Transplant; 2008 May; 23(5):1600-7. PubMed ID: 18175781
[TBL] [Abstract][Full Text] [Related]
2. End-stage renal disease in patients with Fabry disease: natural history data from the Fabry Registry.
Ortiz A; Cianciaruso B; Cizmarik M; Germain DP; Mignani R; Oliveira JP; Villalobos J; Vujkovac B; Waldek S; Wanner C; Warnock DG
Nephrol Dial Transplant; 2010 Mar; 25(3):769-75. PubMed ID: 19846394
[TBL] [Abstract][Full Text] [Related]
3. Enzyme replacement therapy and Fabry nephropathy.
Warnock DG; Daina E; Remuzzi G; West M
Clin J Am Soc Nephrol; 2010 Feb; 5(2):371-8. PubMed ID: 20007680
[TBL] [Abstract][Full Text] [Related]
4. Recommendations and guidelines for the diagnosis and treatment of Fabry nephropathy in adults.
Ortiz A; Oliveira JP; Wanner C; Brenner BM; Waldek S; Warnock DG
Nat Clin Pract Nephrol; 2008 Jun; 4(6):327-36. PubMed ID: 18431378
[TBL] [Abstract][Full Text] [Related]
5. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.
Othman M; Kawar B; El Nahas AM
Nephron Clin Pract; 2009; 113(1):c16-23. PubMed ID: 19590231
[TBL] [Abstract][Full Text] [Related]
6. Estimation of glomerular filtration rate: does haemoglobin discriminate between ageing and true CKD?
Ferrari P; Xiao J; Ukich A; Irish A
Nephrol Dial Transplant; 2009 Jun; 24(6):1828-33. PubMed ID: 19131346
[TBL] [Abstract][Full Text] [Related]
7. Alcohol consumption and 5-year onset of chronic kidney disease: the AusDiab study.
White SL; Polkinghorne KR; Cass A; Shaw JE; Atkins RC; Chadban SJ
Nephrol Dial Transplant; 2009 Aug; 24(8):2464-72. PubMed ID: 19307230
[TBL] [Abstract][Full Text] [Related]
8. Predicting mortality and uptake of renal replacement therapy in patients with stage 4 chronic kidney disease.
Conway B; Webster A; Ramsay G; Morgan N; Neary J; Whitworth C; Harty J
Nephrol Dial Transplant; 2009 Jun; 24(6):1930-7. PubMed ID: 19181760
[TBL] [Abstract][Full Text] [Related]
9. Dialysis and transplantation in Fabry disease: indications for enzyme replacement therapy.
Mignani R; Feriozzi S; Schaefer RM; Breunig F; Oliveira JP; Ruggenenti P; Sunder-Plassmann G
Clin J Am Soc Nephrol; 2010 Feb; 5(2):379-85. PubMed ID: 20056752
[TBL] [Abstract][Full Text] [Related]
10. Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort.
Levin A; Djurdjev O; Beaulieu M; Er L
Am J Kidney Dis; 2008 Oct; 52(4):661-71. PubMed ID: 18805347
[TBL] [Abstract][Full Text] [Related]
11. Pediatric Fabry disease.
Ries M; Gupta S; Moore DF; Sachdev V; Quirk JM; Murray GJ; Rosing DR; Robinson C; Schaefer E; Gal A; Dambrosia JM; Garman SC; Brady RO; Schiffmann R
Pediatrics; 2005 Mar; 115(3):e344-55. PubMed ID: 15713906
[TBL] [Abstract][Full Text] [Related]
12. Classification of chronic kidney disease by estimated glomerular filtration rate.
Marsik C; Endler G; Gulesserian T; Wagner OF; Sunder-Plassmann G
Eur J Clin Invest; 2008 Apr; 38(4):253-9. PubMed ID: 18339005
[TBL] [Abstract][Full Text] [Related]
13. Implementing KDOQI CKD definition and staging guidelines in Southern California Kaiser Permanente.
Rutkowski M; Mann W; Derose S; Selevan D; Pascual N; Diesto J; Crooks P
Am J Kidney Dis; 2009 Mar; 53(3 Suppl 3):S86-99. PubMed ID: 19231766
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of patients with Fabry disease in Argentina].
AADELFA (Asociación Argentina de estudio de enfermedad de Fabry y otras enfermedades lisosomales)
Medicina (B Aires); 2010; 70(1):37-43. PubMed ID: 20228022
[TBL] [Abstract][Full Text] [Related]
15. Investigation of the prevalence of CKD in 13,383 Chinese hospitalised adult patients.
Liu BC; Wu XC; Wang YL; Wang B; Gao J; Zhang QJ; Zhu Y; Zhang XL; Yin LF
Clin Chim Acta; 2008 Jan; 387(1-2):128-32. PubMed ID: 18028892
[TBL] [Abstract][Full Text] [Related]
16. Long-term enzyme replacement therapy is associated with reduced proteinuria and preserved proximal tubular function in women with Fabry disease.
Prabakaran T; Birn H; Bibby BM; Regeniter A; Sørensen SS; Feldt-Rasmussen U; Nielsen R; Christensen EI
Nephrol Dial Transplant; 2014 Mar; 29(3):619-25. PubMed ID: 24215016
[TBL] [Abstract][Full Text] [Related]
17. Females with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry.
Wilcox WR; Oliveira JP; Hopkin RJ; Ortiz A; Banikazemi M; Feldt-Rasmussen U; Sims K; Waldek S; Pastores GM; Lee P; Eng CM; Marodi L; Stanford KE; Breunig F; Wanner C; Warnock DG; Lemay RM; Germain DP;
Mol Genet Metab; 2008 Feb; 93(2):112-28. PubMed ID: 18037317
[TBL] [Abstract][Full Text] [Related]
18. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
[TBL] [Abstract][Full Text] [Related]
19. Clinical spectrum of Anderson Fabry disease in a Romanian family.
Tudor A; Muşat A; Doscan A; Bari M; Zapucioiu C; Urdea E; Cochior D; Peţa D
Rom J Intern Med; 2006; 44(2):201-10. PubMed ID: 17236300
[TBL] [Abstract][Full Text] [Related]
20. Gender-specific reference value of urine albumin-creatinine ratio in healthy Chinese adults: results of the Beijing CKD survey.
Xu R; Zhang L; Zhang P; Wang F; Zuo L; Zhou Y; Shi Y; Li G; Jiao S; Liu Z; Xu G; Liang W; Wang H
Clin Chim Acta; 2008 Dec; 398(1-2):125-9. PubMed ID: 18809395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
